Beyond equity: Why venture debt is reshaping European biotech

0:00-22:35

In this episode of Denatured, you’ll hear from Jennifer McMahon, partner at Seroba and Joey Mason, venture partner at Claret Capital. We dig into how venture debt buys time when equity can’t — and how Europe’s funding gaps, tranching habits and slower urgency shape who uses it well.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsJennifer McMahon, Partner, SerobaJoey Mason, Venture Partner, Claret CapitalDisclaimer: The views expressed in this discussion by guests are their own and do not repr...

Publisher

BioSpace

Published

October 8, 2026

Duration

23 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

B

BioSpace

@biospace

#equity #venturedebt #reshapingeuropeanbiotech #lifesciences

The Nile